Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 92.42B | 90.93B | 93.66B | 86.33B | 109.37B |
Gross Profit | 20.82B | 20.66B | 15.43B | 16.83B | 15.66B |
EBITDA | 11.61B | 10.63B | 8.34B | 6.78B | 8.31B |
Net Income | 3.26B | 2.72B | -2.01B | -1.23B | -368.00M |
Balance Sheet | |||||
Total Assets | 132.32B | 134.05B | 129.21B | 142.33B | 146.74B |
Cash, Cash Equivalents and Short-Term Investments | 13.37B | 12.80B | 10.16B | 10.07B | 8.43B |
Total Debt | 43.10B | 43.42B | 43.02B | 55.43B | 61.60B |
Total Liabilities | 70.09B | 73.18B | 74.33B | 85.30B | 89.52B |
Stockholders Equity | 57.49B | 56.05B | 50.59B | 52.97B | 53.78B |
Cash Flow | |||||
Free Cash Flow | 2.19B | 3.19B | 5.50B | 3.71B | -839.00M |
Operating Cash Flow | 12.50B | 7.36B | 9.29B | 11.86B | 3.97B |
Investing Cash Flow | -10.15B | -3.85B | 4.09B | -3.60B | -5.58B |
Financing Cash Flow | -1.76B | -1.23B | -13.43B | -7.21B | 3.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥25.00B | 8.17 | 4.48% | -0.35% | -14.20% | ||
79 Outperform | ¥68.20B | 11.39 | 7.36% | 2.79% | -10.78% | ||
78 Outperform | ¥55.55B | 8.45 | 2.95% | 4.17% | 22.27% | ||
76 Outperform | €79.95B | 11.84 | 7.66% | 2.63% | 6.19% | 32.01% | |
75 Outperform | ¥496.76B | 20.05 | 4.30% | 2.67% | -1.31% | 15.83% | |
74 Outperform | ¥161.41B | 12.34 | 9.33% | 2.24% | 6.29% | 13.43% | |
67 Neutral | ¥277.37B | 14.70 | 6.81% | 2.50% | 5.06% | -23.65% |
Hokkan Holdings Limited reported a slight increase in net sales and profits for the fiscal year ended March 31, 2025, with net sales reaching ¥92,419 million, a 1.6% increase from the previous year. The company also announced a higher year-end dividend, reflecting its stable financial performance and commitment to returning value to shareholders.
Hokkan Holdings Limited’s Board of Directors has opposed shareholder proposals to amend the Articles of Incorporation concerning the sale and disclosure of cross-shareholdings. The Board argues that the proposed amendments would undermine their strategic management decisions and could harm shareholder interests by enforcing a uniform policy that does not consider the company’s long-term value enhancement and business relationships.